Public Joint Stock Company "Farmak" (UKR:FARM) acquired Ukrainian business of Novator's portfolio company from Novator Partners LLP on June 1, 2023. In related transactions, Farmak acquired two pharmaceutical marketing companies in the Czech Republic and Slovakia. The transactions have been completed after the seller fulfilled the conditions precedent. The acquired target businesses and operations fully comply with the legal requirements and high ethical and corporate standards of Farmak. FinPoint acted as financial advisor and Dentons acted as legal advisor in this transaction.

Public Joint Stock Company "Farmak" (UKR:FARM) completed the acquisition of Ukrainian business of Novator's portfolio company from Novator Partners LLP on June 1, 2023.